Recombinant 15-valent human papillomavirus vaccine (Beijing Health Guard Biotechnology)

重组十五价人乳头瘤病毒疫苗 (北京康乐卫士生物技术股份有限公司)

Report date: 2025/03/18 20:00:05

Base Information

Drug NameRecombinant 15-valent human papillomavirus vaccine (Beijing Health Guard Biotechnology)
Drug Alias Name15-Valent HPV Vaccine (Beijing Health Guard Biotechnology)
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Health Guard Biotechnology Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Health Guard Biotechnology IncLiaoning Chengda Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A